DE69021530D1 - Neue Derivate von A-nor-3-Carboxysteroiden. - Google Patents

Neue Derivate von A-nor-3-Carboxysteroiden.

Info

Publication number
DE69021530D1
DE69021530D1 DE69021530T DE69021530T DE69021530D1 DE 69021530 D1 DE69021530 D1 DE 69021530D1 DE 69021530 T DE69021530 T DE 69021530T DE 69021530 T DE69021530 T DE 69021530T DE 69021530 D1 DE69021530 D1 DE 69021530D1
Authority
DE
Germany
Prior art keywords
carboxysteroids
new derivatives
derivatives
steroid
reductase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69021530T
Other languages
English (en)
Other versions
DE69021530T2 (de
Inventor
Gary A Flynn
Philippe Bey
Thomas R Blohm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69021530D1 publication Critical patent/DE69021530D1/de
Application granted granted Critical
Publication of DE69021530T2 publication Critical patent/DE69021530T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J61/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69021530T 1989-12-29 1990-12-28 Neue Derivate von A-nor-3-Carboxysteroiden. Expired - Fee Related DE69021530T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45886989A 1989-12-29 1989-12-29
US07/580,759 US5100917A (en) 1989-12-29 1990-09-11 Novel a-nor-steroid-3-carboxylic acid derivatives

Publications (2)

Publication Number Publication Date
DE69021530D1 true DE69021530D1 (de) 1995-09-14
DE69021530T2 DE69021530T2 (de) 1996-02-01

Family

ID=27039140

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69021530T Expired - Fee Related DE69021530T2 (de) 1989-12-29 1990-12-28 Neue Derivate von A-nor-3-Carboxysteroiden.

Country Status (20)

Country Link
US (1) US5100917A (de)
EP (1) EP0435321B1 (de)
JP (1) JP3039996B2 (de)
KR (3) KR0178468B1 (de)
CN (4) CN1033809C (de)
AT (1) ATE126232T1 (de)
AU (1) AU634326B2 (de)
CA (1) CA2033392C (de)
DE (1) DE69021530T2 (de)
DK (1) DK0435321T3 (de)
ES (1) ES2078291T3 (de)
FI (1) FI94418C (de)
GR (1) GR3017559T3 (de)
HU (1) HU210340B (de)
IE (1) IE67511B1 (de)
IL (1) IL96790A (de)
MX (1) MX9203338A (de)
NO (1) NO180719C (de)
NZ (1) NZ236589A (de)
PT (1) PT96394B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993013124A1 (en) * 1991-12-20 1993-07-08 Glaxo Inc. Inhibitors of 5-alpha-testosterone reductase
EP0641211A1 (de) * 1992-05-21 1995-03-08 Endorecherche Inc. Testosteron-5-alpha-reduktase-inhibitonen
US5302589A (en) * 1992-08-07 1994-04-12 Glaxo, Inc. Heterocyclic inhibitors of 5-α-testosterone reductase
GB9224148D0 (en) * 1992-11-18 1993-01-06 Smithkline Beecham Corp Compounds
US5561124A (en) * 1992-11-18 1996-10-01 Webb; Robert L. 17-α-acyl steroids which inhibit 5-α-reductase
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9668972B2 (en) * 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8119109B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
EP1556009B2 (de) 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Kosmetischer und pharmazeutischer schaum
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
FR2857968B1 (fr) * 2003-07-25 2006-02-03 Inovat Sarl Nouveaux derives steroides et leurs utilisations therapeuthique
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
CA2610662A1 (en) * 2005-05-09 2007-05-18 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
WO2009007785A2 (en) * 2006-11-14 2009-01-15 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
EP2242476A2 (de) * 2008-01-14 2010-10-27 Foamix Ltd. Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
JP5527236B2 (ja) * 2011-01-31 2014-06-18 信越化学工業株式会社 ポジ型化学増幅レジスト材料、パターン形成方法及び酸分解性ケトエステル化合物
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3336338A (en) * 1963-09-13 1967-08-15 Squibb & Sons Inc A-nor-cholestatriene-21-oic acid 21->24 lactones
US3600425A (en) * 1963-09-13 1971-08-17 Squibb & Sons Inc Synthesis of steroids
US3484476A (en) * 1963-09-13 1969-12-16 Squibb & Sons Inc A-nor steroids
US3424751A (en) * 1965-10-20 1969-01-28 Du Pont Selected 2-formyl-and 2alpha-(cyanoamidino)-a-nor-5alpha-androstane derivatives
US3492359A (en) * 1966-01-14 1970-01-27 Squibb & Sons Inc 11,12-oxo and/or oxy substituted a-norpregnenes
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors

Also Published As

Publication number Publication date
CN1033809C (zh) 1997-01-15
ATE126232T1 (de) 1995-08-15
CA2033392A1 (en) 1991-06-30
JP3039996B2 (ja) 2000-05-08
CN1127257A (zh) 1996-07-24
AU634326B2 (en) 1993-02-18
FI906438A (fi) 1991-06-30
MX9203338A (es) 1992-09-01
IE67511B1 (en) 1996-04-03
EP0435321A3 (en) 1992-04-29
IL96790A0 (en) 1991-09-16
PT96394A (pt) 1991-10-15
HU908495D0 (en) 1991-07-29
EP0435321B1 (de) 1995-08-09
FI94418C (fi) 1995-09-11
KR910011887A (ko) 1991-08-07
JPH04134094A (ja) 1992-05-07
IL96790A (en) 1995-03-15
CN1036200C (zh) 1997-10-22
ES2078291T3 (es) 1995-12-16
DE69021530T2 (de) 1996-02-01
KR0178470B1 (ko) 1999-04-01
DK0435321T3 (da) 1995-09-18
FI94418B (fi) 1995-05-31
CN1127258A (zh) 1996-07-24
PT96394B (pt) 1998-10-30
AU6844790A (en) 1991-07-04
NO905608L (no) 1991-07-01
KR0178468B1 (ko) 1999-04-01
GR3017559T3 (en) 1995-12-31
US5100917A (en) 1992-03-31
NO180719B (no) 1997-02-24
NZ236589A (en) 1993-02-25
HUT56379A (en) 1991-08-28
HU210340B (en) 1995-03-28
KR0178471B1 (ko) 1999-04-01
NO905608D0 (no) 1990-12-27
CN1052866A (zh) 1991-07-10
NO180719C (no) 1997-06-04
IE904720A1 (en) 1991-07-17
CA2033392C (en) 2002-08-27
CN1127256A (zh) 1996-07-24
EP0435321A2 (de) 1991-07-03
FI906438A0 (fi) 1990-12-28

Similar Documents

Publication Publication Date Title
DE69021530D1 (de) Neue Derivate von A-nor-3-Carboxysteroiden.
ATE415394T1 (de) Zwischeprodukte zur herstellung von retroviralen protease-hemmern
DE69128516T2 (de) Neue Mercaptoacetylamid-Derivate zur Verwendung als Enkephalinase- und ACE-Hemmer
ATE58896T1 (de) Neue zwischenprodukte und verfahren zur herstellung von 3-acylamino-1-hydroxy-2azetidinonen.
BG92804A (bg) 4-бензоилизоксазолови производни
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
NO903148L (no) Hemoreguleringspeptider.
DE3486438D1 (de) Verfahren zur Herstellung von 1-(Phenyl)-1-hydroxy-2-amino-3-fluor-propan-Derivaten
DE69326474D1 (de) Neue 2-substituierte tricyclische derivate von indan-2-mercaptoacetylamid verwendbar als enkephalinase inhibitoren
FI892222A0 (fi) Peptidalkoholer med antikoagulantverkan.
ATE69220T1 (de) Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
ATE118209T1 (de) Pyridin-3-percarboxylsäure monopersulfat.
NO842345L (no) Heksahydropyrrolo(2,1-a)isoquinolin-derivater.
ES2089281T3 (es) Nuevos derivados de 2-mercaptometileno-tetrahidronaftaleno y 2-carboxamida indanos como inhibidores de la encefalinasa.
DE3461189D1 (en) New 3-alkylthio-2-o-carbamoyl-propane-1.2-diol-1-o-phosphocholines, and processes for their preparation
DE3672635D1 (de) Esterderivate von 2,2-dimethyl-3-ethenylcyclopropancarbonsaeure, ihre herstellung, ihre verwendung als parasitizide und sie enthaltende zusammensetzungen.
ATE66671T1 (de) Gamma-l-glutanyl-4-nitoanilid-derivate und verfahren zur bestimmung von gamma-gtp-aktivitaet unter verwendung dieser derivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee